Regulatory PathRegulatory requirements compared

Active substance

Dequalinium

Open in the medicines table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
DEQUADIN021002070.25 MGLOZENGE · ORALPHARMASCIENCE INC
VABLYS0251825210 MGVAGINAL TABLET · VAGINALDUCHESNAY INC

UK MHRA United Kingdom — marketing authorisations

ProductAuthorisationHolderLegal status
FLUOMIZIN 10 MG VAGINAL TABLETSPL 04854/0194GEDEON RICHTER PLCPOM

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.